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EDITORIAL
Year’s comments for 2006
The end of the twentieth century marked the beginning of a
unique period in microbiology, such that microorganisms are
now being studied from both ends of the biological spectrum:
as the driving forces behind biological processes in the bios-
phere and as microscopic laboratories for studying these and
other processes at the molecular level [2]. Microbes pervade
most biological disciplines, and they have been the subject of
increasing media attention due to both their positive and neg-
ative aspects. Thus, com-
menting on the achieve-
ments in the field of
microbiology in 2006 as
well as on the news relat-
ed to microbiology pub-
lished in the mass media
would fill an entire issue
of INTERNATIONAL MICRO-
BIOLOGY. Therefore, let us
focus on just a few of this
year’s highlights.
In its Year’s Com-
ments for 2005, INTER-
NATIONAL MICROBIOLOGY
noted the Nobel Prize in
Physiology or Medicine,
which was awarded to the
discoverers of the role of
Helicobacer pylori as the causal agent of gastric ulcers (Fig 1).
In 2006, two Nobel Prizes (Physiology or Medicine, and
Chemistry) were also related to microbiology. The Nobel
Prize in Physiology or Medicine was awarded to Andrew Z.
Fire, from Stanford University, and Craig C Mello, from the
University of Massachusetts-Worcester, for their discovery
of “RNA interference—gene silencing by double-stranded
RNA”. Since this mechanism for controlling the flow of
genetic information occurs in plants, animals, and humans, it
may seem, at first glance, to have nothing to do with micro-
biology. However, RNA interference plays a major role in
defending not only these organisms against viruses, but also
“lower” organisms. In RNA interference, the presence of
double-stranded RNA molecules in the cell triggers the bio-
chemical machinery to degrade those mRNA molecules that
carry a sequence identi-
cal to that of the double-
stranded RNA. As a
result, the mRNA from a
specific gene is degrad-
ed. The disappearance of
those mRNA molecules
silences the correspon-
ding gene, and the
respective protein is no
longer produced. Thus,
cells infected by double-
stranded RNA viruses
are able to overcome the
infection when the RNA
of the infecting virus is
degraded by means of
RNA interference. 
The 2006 Nobel Prize
in Chemistry was awarded to Roger Kornberg, from Stanford
University, for his fundamental studies of the molecular basis of
eukaryotic transcription. Kornberg has worked on transcription
since 1974, when he was a postdoctoral student with Francis
Crick and Aaron Klug, at the British Medical Research Council
in Cambridge, UK. Kornberg chose Saccharomyces cerevi-
siae as the model organism for his research. The breakthrough
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Fig. 1. Prof. Barry J. Marshall, 2005 Nobel laureate in Physiology or Medicine, holding
an issue of our journal on the premises of the Barcelona City Hall (June 19, 2006). 
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resulting from almost three decades of research came in
2001, when his team published two articles in Science
describing the structure of a 10-subunit yeast polymerase at
2.8 Å resolution, and of an elongating complex consisting of
RNA polymerase, template DNA, and product RNA. An
understanding of the mechanisms of transcriptional regula-
tion is crucial to our attempts to treat cancer as well as car-
diac and metabolic diseases, to understand the basis of
inflammation, and to control and direct the development of
stem cells into highly differentiated ones.
The June 2006 issue of Lancet Infectious Diseases con-
tained the results of a meta-analysis evaluating evidence for
the increasingly popular but nonetheless controversial use of
probiotics in the prevention of acute diarrhea. Of the 690
publications identified in the first search by the authors, only
28 studies they described fulfilled the eligibility criteria for
inclusion in the analysis (the article referred to 34 trials
because five of the original trials presented two or more inde-
pendently analyzable results that could be considered as sep-
arate trials [6]). One of those studies had been published in
INTERNATIONAL MICROBIOLOGY in 2004 [5]. The controversy
surrounding the efficacy of probiotics in preventing various
kinds of diarrhea extends beyond scientific boundaries, and
is further complicated by the fact that scientists involved in
research into this topic often have conflict of interest.
Moreover, the scope of the debate to clearly define “probiot-
ic” has reached the realm of politics. In Spain, for example,
since 2003 and based on a politically motivated decision,
yogurt that has been pasteurized can still be called yogurt, in
flagrant violation of the recommendations of the Codex
Alimentarius Commission.
According to the latest World Health Organization
(WHO) and UNAIDS (the Joint United Nations Programme
for HIV/AIDS) report on the AIDS epidemic [8], around 24.7
(21.8–27.7) million people from sub-Saharan Africa are
infected with HIV. Worldwide, they account for 63% of all
people infected with the virus, with southern Africa being the
focus of the AIDS epidemic. Unfortunately, the forecast
made by UNAIDS in 2004, that by 2010 some five million
new infections would occur annually [1], appears to be accu-
rate. Despite more effective and accessible treatment and the
implementation of prevention programs in many countries,
the number of people infected has continued to grow. In
2006, the global number of new infections was estimated at
4.3 (3.6–6.6) million adults and children. Adult women are
the most affected group; in sub-Saharan Africa, there are
about 14 adult women living with HIV for every infected
man. In 1951, in what has become a classic WHO mono-
graph, Charles Edward Winslow (1877-1957), a leading
voice in Public Health, professor at Yale University, consid-
ered poverty as a major factor in the cause and spread of dis-
ease and commented on the mutual relationship that,
throughout history, has established a vicious circle of pover-
ty and sickness: “Men and women were sick because they
were poor, they became poorer because they were sick, and
sicker because they were poorer.”[9]. Unfortunately, the
same can be said of the AIDS epidemic. Likewise, access to
suitable drugs is not enough to prevent the disease; other
changes addressing the roots of the problem are necessary.
Since the field of genomics is by now well-established
and the sequencing of microbial genomes has become rou-
tine, it is the peculiarities found in those genomes that have
made the news. The October 13, 2006 issue of Science con-
tained reports of the two smallest genomes known so far: that
of Buchnera aphidicola BCc (primary endosymbiont of the
aphid Cinara cedri, with a circular chromosome of around
416 kb plus a 6.045-kb plasmid), reported by a Spanish group
from the Cavanilles Institute, in Valencia, Spain [4], and that
of Carsonella rudii strain Pv (the only symbiont of the psyl-
lid Pachypsylla venusta, with a circular chromosome of
around 160 kb), reported by a group of Japanese and
American scientists [3]. In addition to their small sizes, the
two genomes have in common their high stability and lack of
genes for many bacterial metabolic functions. Although other
strains of B. aphidicola had been sequenced, they had larger
genomes (615–641 kb) and greater metabolic capabilities.
Interestingly, B. aphidicola BCc might be losing its symbiot-
ic capacity. In fact, this primary endosymbiont is comple-
mented by a coexisting secondary endosymbiont that could
eventually replace it. In the case of C. rudii, the lack of many
genes for bacterium-specific processes can be explained by
the transfer of some bacterial genes to the genome of an
ancestor of its current host, with which the bacterium could
have coevolved. It remains to be demonstrated whether C.
rudii is still a bacterial cell, and not an evolved organelle.
The spread of drug-resistant pathogens continues. The
already-known antibiotic-resistant bacteria, methicillin-
resistant Staphylococcus aureus (MRSA), were found in 75%
of serious skin infections treated at clinics in Atlanta,
Georgia, USA [7], and across that country. The reemergence
of tuberculosis during the last few decades has posed anoth-
er threat to humans due to the development of drug-resistant
Mycobacterium tuberculosis strains. To date, resistant strains
of M. tuberculosis have been found in all regions of the
world, thereby qualifying the bacterium for membership in
the superbug “club.” In the 1990s, the WHO recommended
the DOTS strategy to control tuberculosis. DOTS, which
stands for “directly-observed treatment short-course”, is a
comprehensive strategy based on five elements: (i) political
commitment, (ii) quality sputum microscopy for diagnosis,
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(iii) a regular supply of antituberculosis drugs, (iv) standard-
ized recording and reporting of tuberculosis data, and (v)
supervised treatment by a treatment partner. However, epi-
demiological data indicate that DOTS alone is not enough to
stop the spread of tuberculosis and the WHO has established
a new strategic plan for the period 2006–2015 to fight the
disease (DOTS Expansion: Working Group Strategic Plan
2006–2015; available at [http://whqlibdoc.who.int/hq/2006/
WHO_HTM_TB_2006.370_eng.pdf]).
* * *
INTERNATIONAL MICROBIOLOGY has received its first “Impact
Factor” (IF) from Thomson Scientific (Philadelphia, PA,
USA). The 2005 IF is 1.868, which makes INTERNATIONAL
MICROBIOLOGY the fourth (out of 30) Spanish scientific and
technological journals included in the Current Contents.
Publishing thematic issues has become a tradition in our jour-
nal. The mini-reviews that make up the monographs are usu-
ally contributions from a microbiology-related meeting. For
example, to commemorate the 50th anniversary of the publi-
cation of the seminal book The Microbe’s Contribution to
Biology, by AJ Kluyver and CB van Niel (Harvard Uni-
versity Press, 1956), an international symposium was held in
Barcelona on April 27 and 28, 2006. The September 2006
issue of INTERNATIONAL MICROBIOLOGY contained contribu-
tions presented at this symposium, which was organized
jointly by the Fundación Ramón Areces (Madrid) and the
Institute for Catalan Studies (Barcelona). The Editorial of the
issue was written especially for it by Joshua Lederberg.
INTERNATIONAL MICROBIOLOGY readers that make use of
the online version of the journal may have noticed the recent
changes that our webmaster introduced to make the site more
user-friendly. Of the journal’s viewers who access the journal
directly through its website and whose country could be
determined, 20% were from Spain, 25% were from North
America (USA, 17.4%, Mexico, 4.4%, and Canada, 3.2%),
6% from India, 4.4% from the UK, and 3.7% from Germany.
Over the last few years, our journal has become even more
“international” (in 2004, the journal’s Spanish viewers
accounted for 39.4% of the total), not only regarding its
Internet readership, but also considering the origin of the arti-
cles published. Even though most research and review arti-
cles published in 2006 came from Spanish centers (18 out of
32), there were four articles from the United States, two from
Brazil, two from Germany, and 1 each from Australia,
Canada, Colombia, France, Ireland, and Portugal. Now that
the journal has an impact factor, the number of manuscripts
received has significantly increased. The increase in the num-
ber of original articles received by the journal has meant
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more editorial work and more submissions to reviewers,
those anonymous people who ensure the journal’s high qual-
ity, and to whom we are extremely grateful.
On November 7, 2005, the Spanish Boletín Oficial del
Estado (Spanish Official Gazette) published the criteria for
evaluating research. Regarding the publication of research
results, the quality of the means of diffusion was considered
an aspect of great importance. In addition to being indexed in
prestigious international databases, a means of diffusion
must exert a minimum level of impact. The criteria selected
in the report focused on (i) the quality of the journal as a
means for scientific communication; (ii) the quality of the
editorial process; and (iii) the scientific quality of the journal.
INTERNATIONAL MICROBIOLOGY fulfils all these requirements.
The policy of open access to the scientific literature,
which INTERNATIONAL MICROBIOLOGY has always supported
and applied, has gained widespread acceptance, but it also
continues to be fought by the “big” commercial publishers.
Currently, the recipients of grants from several public institu-
tions, in Europe and the USA, are required to make the
results of research funded by those institutions freely acces-
sible—either from the very beginning or within a few months
after publication. Both journals and authors must adapt
accordingly, but changes in the budgets of grants are also
necessary. The process of producing an article from a manu-
script received at a journal’s editorial office is complex and,
even for those journals whose staff works on a voluntary
basis, there are considerable expenses that must somehow be
reimbursed. Who is going to bell the cat? Many commercial
publishers as well as learned societies that base most of their
income on the sales of their journals are reluctant to join the
Open Access Initiative (OAI). By contrast, most authors have
already realized that open access favors the citation of arti-
cles. The British Society for General Microbiology (SGM),
which publishes Microbiology, Journal of Medical Microbio-
logy, Journal of General Virology, and International Journal
of Systematic and Evolutionary Microbiology, commented on
the decision adopted by the SGM regarding its journals in its
bulletin [Microbiology Today, August 2006, p. 140]. An
important percentage of articles published in the SGM jour-
nals reported research funded by the British Welcome Trust,
which notified its grant-holders that they must provide free
access to articles arising from work funded by the Trust.
Even though most opinions in favor or against open access
are based on economic grounds, there is an overwhelming
reason for joining the OAI: making it possible that knowl-
edge is accessible to anybody, especially to researchers from
developing countries that cannot afford—either by them-
selves privately or by their universities or research centers—
to pay for journal subscriptions.
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Since its very beginning INTERNATIONAL MICROBIOLOGY
has developed programs to promote scientific relationships
with Latin American microbiologists. For example, as soon
as the electronic version of the journal is online, the index is
made available not only to members of the Spanish Society
of Microbiology (SEM) but also to those of any Latin
American microbiology society who send their emails to the
editorial office. Some Spanish microbiology groups have
guaranteed that copies of the printed journal reach Latin
American centers or individual researchers by transferring
their own institutional subscriptions. Another initiative of the
journal in support of Latin American microbiology is the
reproduction, on the back cover of the journal, of the portraits
and signatures of great Latin American microbiologists. Brief
biographies, including comments on the significance of the
work of these scientists, are included on the inside title page
of the journal.
The SEM has established and strengthened relationships
with various foreign and international microbiological soci-
eties. The meeting on microbiological societies held in
Madrid in June 2003, at the Fundación Ramón Areces, which
has generously sponsored many of the SEM’s activities for
many years, laid the foundations for a sound collaboration
between the SEM and the American Society for Microbio-
logy (ASM). This collaboration has intensified every year
since then (Fig. 2). The European Federation of Microbiolo-
gical Societies (FEMS) held its 2nd Congress in Madrid on
July 4-7, 2006. The SEM intensively collaborated in the
organization of the meeting (see a report by VJ Cid on p. 303
of this issue). Each of the 1500 attendants, from many differ-
ent countries, received a copy of the June issue of
INTERNATIONAL MICROBIOLOGY. The SEM belongs to FEMS
since the foundation of the Federation, thirty-one years ago.
The SEM was also present at the 18th Congress of the Latin
American Association for Microbiology (ALAM), held in
conjunction with the 28th Chilean Congress of Microbiology
and the 3rd Chilean Congress of Food Microbiology, in
Pucón, Chile, on October 23-26, 2006 (see a report by DS
Holmes and G Mora on p.306 of this issue).
To conclude, INTERNATIONAL MICROBIOLOGY is a journal
that is produced and published with scarce resources but with
great enthusiasm, and is now entering its tenth year. We are,
as we once said, “staunchly resisting improbability”. These
efforts are worthwhile if we can continue to improve and
spread the knowledge of microbiology and an appreciation of
the ubiquity and diversity of microorganisms on our planet.
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Fig. 2. Plate presented by the ASM International Committee to the SEM dur-
ing the 106th ASM General Meeting (Orlando, Florida, 21-25 May 2006).
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